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Abstract
A popular method for estimating a causal treatment effect with observational data is the difference-
in-differences (DiD) model. In this work, we consider an extension of the classical DiD setting to the
hierarchical context in which data cannot be matched at the most granular level (e.g., individual-level
differences are unobservable). We propose a Bayesian hierarchical difference-in-differences (HDiD) model
which estimates the treatment effect by regressing the treatment on a latent variable representing the
mean change in group-level outcome. We present theoretical and empirical results showing that an
HDiD model that fails to adjust for a particular class of confounding variables, or confounding with
the baseline (pre-treatment) outcomes, biases the treatment effect estimate. We propose and implement
various approaches to perform variable selection using a structured Bayesian spike-and-slab model in
the HDiD context. Our proposed methods leverage the temporal structure within the DiD context to
select those covariates that lead to unbiased and efficient estimation of the causal treatment effect. We
evaluate the methods’ properties through theoretical results and simulation, and we use them to assess
the impact of primary care redesign of clinics in Minnesota on the management of diabetes outcomes
from 2008 to 2017.
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1 Introduction
1.1 Difference-in-differences models
A common task in biostatistics is to estimate a treatment effect with observational data. A major issue
in making causal inferences from observational studies is the virtually unavoidable presence of confounding
variables. A popular observational method that avoids the effect of static confounders, or confounding
variables whose values and relation to the outcome do not change over time, is the difference-in-differences
(DiD) model. DiD estimation first defines a treatment and an outcome. Under the classical setting the
treatment is binary, defining two groups (e.g., “treatment” and “control”). The standard DiD model tests
for a difference between the average change in outcome over time in the treatment group and the average
change in outcome over time in the control group. Specifically, it takes the difference in mean outcome
between the groups before the treatment (Difference 1), takes the difference in mean outcome between
the groups after the treatment (Difference 2), and then takes the difference between those two differences
(Difference 2 - Difference 1). The DiD model is used often in econometrics, social science, and marketing.
As a canonical example of applying the DiD model, Card & Krueger compared the change in employment
in New Jersey vs. Pennsylvania after New Jersey adopted an increase in the minimum wage; in this context
New Jersey could be considered the treatment group and Pennsylvania the control group.1
Formally, let Y
(t)
i denote the outcome variable for subject i = 1, ..., n at timepoint t ∈ {0, 1}, where t = 0
indicates the measurement was taken before the treatment and t = 1 indicates the measurement was taken
after the treatment. Let T
(t)
i denote the treatment status for individual i at timepoint t. The observed
treatment level for individual i is then Ti ≡ T (1)i −T (0)i . In the DiD framework, with a binary treatment, the
“treatment” group’s treatment status is Ti = T
(1)
i − T (0)i = 1 − 0 = 1 and the “control” group’s treatment
status is Ti = T
(1)
i − T (0)i = 0 − 0 = 0. In the continuous case, subject i’s treatment status is simply
Ti = T
(1)
i − T (0)i . A common DiD model is
Y
(t)
i = β0 + φ1(t = 1) + ∆Ti1(t = 1) + 
(t)
i (1)
where β0 is the pre-treatment mean of the control group, φ is the common time trend assumed for each
subject, ∆ is the treatment effect of interest, 1 is the indicator function, and 
(t)
i is the subject’s normally
distributed residual at timepoint t. In this formulation, ∆ is the expected difference in post-treatment
outcome for an individual, if they receive the treatment rather than the control. To define ∆ formally, we
use the potential outcomes notation introduced in the Rubin causal model.2 Letting Yi(Ti = c) denote the
potential outcome of subject i had they received treatment c, ∆ is defined as the average treatment effect
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in the post-treatment timepoint: ∆ = E
[
Y
(1)
i (Ti = 1)− Y (1)i (Ti = 0)
]
.
The typical DiD estimator is the observed difference between the average observed trend in the treated
group and the average observed trend in the control group: ∆ˆ =
(
Y¯
(1)
Tj=1
− Y¯ (0)Tj=1
)
−
(
Y¯
(1)
Tj=0
− Y¯ (0)Tj=0
)
. If
certain identifying assumptions are satisfied, then ∆ˆ is an unbiased and consistent estimator of ∆.3 Using
∆ˆ to estimate ∆ differences out the effect of static confounders, eliminating the need to adjust the model
for them. However, an important identifying assumption is the absence of dynamic confounders, which are
confounding variables whose values or relation to the outcome change over time.
More generally, the treatments Ti may be non-binary or continuous. In this setting, only one of the
potential outcomes
{
Y
(1)
i (Ti = c)
∣∣ c ∈ T }, where T denotes the support of T , is observed. Here, ∆ gives
the expected difference in post-treatment outcome for an individual if they receive an additional unit of
exposure:
∆ = E
[
Y
(1)
i (Ti = c+ 1)− Y (1)i (Ti = c)
]
. (2)
1.2 Covariate adjustment and selection
Adjusting an estimator of a causal treatment effect to eliminate confounding is a well-explored topic in
the single timepoint context. Propensity score matching and inverse probability of treatment weighting
are popular methods which use conditional exchangeability (i.e., conditional on some other covariate(s),
treatment groups are comparable) to eliminate confounding.4,5 However, these methods require adjustment
for all confounding variables to estimate the treatment effect consistently.
More recently, approaches which jointly estimate outcome and exposure/treatment models, and then
leverage information across each model to estimate the treatment effect have been proposed. Wang et
al. and Cefalu propose methods which identify potential confounders by imposing prior dependence on a
covariate’s inclusion in the propensity score and outcome models.6,7 Zigler and Dominici propose Bayesian
methods that perform variable selection, then estimate the treatment effect as a weighted average of estimates
yielded from propensity score models with different covariates included.8 Koch et al. propose a method
which simultaneously estimates the treatment effect while performing an adaptive group lasso based variable
selection algorithm.9
In the point-exposure context, confounding occurs when a covariate is associated with both treatment
and outcome. In the DiD context, confounding occurs when (i) the covariate is associated with treatment
and (iia) the association between the covariate and outcome varies over time or (iib) the covariate evolves
over time differently in the treatment and control groups.10 Thus, identifying the causal effect (2) may
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require extending model (1) as follows:
Y
(t)
i = β0 + φ1(t = 1) + ∆Ti1(t = 1) +
K∑
k=1
β
(t)
k X
(t)
ik + 
(t)
i . (3)
Static covariates (X
(0)
ik = X
(1)
ik ) may still be confounders of type (iia) if β
(0)
k 6= β(1)k ; confounders of type (iib)
require X
(0)
ik 6= X(1)ik .
Many applications of the covariate-adjusted DiD model directly select the covariates without any data-
driven variable selection techniques.11–13 Stuart et al. uses propensity scores to increase comparability of the
four DiD groups (treatment-pre, control-pre, treatment-post, control-post).14 Sofer et al. interpret the DiD
model as a negative control outcome to identify and correct for biased DiD-estimated treatment effects.15
An often used Bayesian variable selection approach is spike-and-slab variable selection, which proceeds
by specifying a two-component mixture prior on each regression coefficient. In George & McCulloch’s imple-
mentation, the spike and slab are mean 0 Gaussian distributions with low and high variances, respectively:
βk|wk, z2k, c2 ∼ (1− wk)N(0, z2k) + wkN(0, c2z2k),
wk|p ∼ Bernoulli(p), k = 1, ...,K,
(4)
where wk = 1 indicates βk was selected for the slab and wk = 0 indicates βk was selected for the spike.
16
To make this formulation work, z2k is chosen to be small and c
2 is chosen to be large. If the data suggest βk
is nonzero, it will have more posterior mass under the slab prior and thus its corresponding covariate will
be included in the model. If the data suggest βk is close to zero, it will have more posterior mass under the
spike prior and thus its corresponding covariate will be excluded from the model. In this paper, we base our
proposed variable selection methods on modified versions of this spike-and-slab prior.
1.3 Hierarchical difference-in-differences models
For model (3), it is often sufficient to consider the change in outcome for each individual:
Y diffi = φ+ ∆Ti +
K∑
k=1
βkXik + i (5)
where Y diffi = Y
(1)
i − Y (0)i and i = (1)i − (0)i . For static covariates (i.e., Xik = X(1)ik = X(0)ik so that
βk = β
(1)
k −β(0)k ) and dynamic covariates with constant association with the outcome (i.e., Xik = X(1)ik −X(0)ik
so that βk = β
(1)
k = β
(0)
k ), this is a classical linear model, in which estimation and inference proceeds with
well-understood theoretical results.
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We instead consider the hierarchical context in which change is not observed at the most granular level
(e.g., not observed for individuals). Our motivating example is an application to assess the impact of
primary care redesign policy on diabetes outcomes at clinics in Minnesota. Individual outcomes are not
matched longitudinally, and thus the mean change in outcome, treatment(s), and covariates are measured
at the clinic level.
To circumvent these restrictions, one could alter the model in Equation (1) to allow for multiple (po-
tentially continuous) treatment levels (e.g., dose-response relationships) as well as adjust for group-level
dynamic confounders in a hierarchical fashion:
Y
(0)
ji ∼ N(µj , σ˜2j )
Y
(1)
ji ∼ N(µj + µdiffj , σ2j )
µj ∼ N(Tj∆˜ +XTj β˜, τ˜2)
µdiffj ∼ N(Tj∆ +XTj β, τ2),
(6)
where j is extended to J groups (e.g., clinics), j = 1, ..., J , µj is the pre-treatment mean outcome of group
j, µdiffj is the mean change in outcome of group j from t = 0 to t = 1, and X is a design matrix comprised
of group-level covariates with rows XTj . σ˜
2
j and σ
2
j are group-j specific outcome variances pre- and post-
treatment, respectively, Tj is the treatment exposure of group j, and τ˜
2 and τ2 are the variances of the
pre-treatment mean outcome and mean change, respectively. We collect the group-level treatment exposures
Tj in a vector T . To measure multiple treatment effects, one could alter Equation (6) extending the vector
T to a matrix of group-level exposures and the scalar ∆ to a vector of treatment effects. We focus on
estimating one treatment effect in this paper. We clarify that adjustment for T in the third line of (6)
does not reflect our belief that T drives pre-treatment values of µ, rather we include it here to control for
confounding factors related to both T and µ; this will be discussed more in depth in Section 2.4.
For the remainder of the paper, we refer to the third and fourth lines of Equation (6) as the “baseline” and
“change” models, respectively, and Equation (6) as a hierarchical difference-in-differences model (HDiD).
An analogous model was first introduced by Normington et al., with a discussion of required assumptions
for this model to identify the causal effect (2).17 In this hierarchical context it is often *not* sufficient to
consider change only; it is necessary to model both baseline and change (µj and µ
diff
j ) together as discussed
in Section 2.
After specifying the likelihood in Equation (6), we choose to proceed with Bayesian inference throughout
this paper as the structure of Equation (6) naturally lends itself to a Bayesian hierarchical model. After
assigning priors, we can simply compute the posterior distribution of each parameter with standard Markov
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chain Monte Carlo (MCMC) techniques. Bayesian inference also facilitates incorporating prior information,
if available, about model parameters, most importantly ∆ in this context.
1.4 Our contribution
In this paper, we motivate and implement four variable selection methods in the HDiD framework, explore
the operating characteristics therein, and apply the methods to a motivating data set. Section 2 discusses
the role of confounding within the context of the model in Equation (6), suggesting which candidate variables
lead to unbiased and efficient estimation of ∆ through simulation. Section 3 proposes four algorithms to
perform variable selection in the HDiD framework. Section 4 conducts a simulation study to assess how each
algorithm performs under a set of underlying truths. Section 5 applies these variable selection techniques to
study of the effect of primary care redesign policy on diabetes outcomes at participating clinics in Minnesota.
Section 6 concludes the work and offers future directions for study in this topic.
2 Covariate adjustment in hierarchical difference-in-differences mod-
els
2.1 Causal relationships of interest
Before motivating the variable selection techniques, we first consider a simple example of the assumed data
generation in Equation (6). The observed subject-level pre-treatment outcome Y
(0)
ji is assumed to arise from
a group j-specific pre-treatment mean µj and the observed subject-level post-treatment outcome Y
(1)
ji is
assumed to arise from a group j-specific pre-treatment mean µj modified by a group j-specific mean change
µdiffj . It is then assumed that µj and µ
diff
j arise from a mean structure modified by covariates through the
design matrix X and treatment vector T ; this includes the treatment T possibly affecting µdiff, as well as
variables which could affect any combination of T , µdiff, and µ.
For our theoretical and simulation evaluations, we consider a hypothetical set of covariates that cover
each of the 23 = 8 combinations of does/does not affect T , does/does not affect µ, and does/does not affect
µdiff; Table 1 lists these cases. Additionally, Figure 1 displays the assumed data generation process as a
directed acyclic graph18 and was generated using the “DAGitty” R package.19 Our goal is to estimate the
causal effect of T on µdiff, represented by the green line in Figure 1.
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2.2 Data generation
Throughout this work, we use simulation to assess the operating characteristics of our approaches. Below,
we describe the data generation used in each simulation.
1. Generate group-level covariate matrix X, where each column Xk is generated as Xk
iid∼ NJ (0, IJ ),
where IJ is the J-dimensional identity matrix.
2. Generate group-level T ∼NJ (Xα, IJ ).
3. Generate group-level µ ∼NJ (Xβ˜, IJ ) and µdiff ∼NJ (T∆ +Xβ, IJ ).
4. Generate subject-level Y
(0)
ji ∼ N(µj , 1) and Y (1)ji ∼ N(µj + µdiffj , 1), for j = 1, ..., J and i = 1, ..., n(t)j .
So, α controls which variables are predictive of treatment, β˜ controls which variables are predictive of
baseline mean, and β controls which variables are predictive of change in means. For each simulation, we
use either J = 50 or J = 100 groups, each having n
(0)
j = n
(1)
j = 10 subjects, j = 1, ..., J . For example,
a generative model that includes all 8 hypothetical covariates in Table 1 and Figure 1 is given by setting
α = [1, 1, 1, 1, 0, 0, 0, 0], β˜ = [1, 1, 0, 0, 1, 1, 0, 0], β = [1, 0, 1, 0, 1, 0, 1, 0], ∆˜ = 0, and ∆ = 1.
Since ∆ measures the covariate-adjusted relationship between T and µdiff, it may not be intuitive why
Equation (6) includes a covariate-adjusted baseline model. Even if the change model is appropriately speci-
fied, estimates of ∆ may still be biased if predictors correlate with µ, µdiff, and T but are not included in
the baseline model.17 In the following sections, we measure the bias and efficiency of ∆ incurred by omitting
important predictors of treatment, baseline, and change. In Section 2.3 we apply a familiar theoretical result.
In Section 2.4, we conduct a simulation to investigate the role adjusting (or not adjusting) the baseline and
change models for individual covariates plays in estimating ∆.
2.3 Omitted variable bias
After marginalizing Y (0) and Y (1) over µ and µdiff and then concatenating them into a vector Y , the model
in (6) can be re-expressed as Y ∼N(AB1Θ1,Σ), where A ≡
A0 0
0 A1
 assigns pre- and post-treatment
group-level predictors to the subject level, B1 ≡
Xw˜=1 T˜ 0 0
Xw˜=1 T˜ Xw=1 T
 such that Xw˜=1 and Xw=1 are
those covariates that are included in the baseline and change models (respectively) and T˜ is T when T is
included in the baseline model and 0 when it is not, and Θ1 ≡ [β˜w˜=1 ∆˜ βw=1 ∆]T . Whereas {B1,Θ1} define
the model used for estimation, assume the true generative model is Y ∼N(ABΘ,Σ) where B ≡ [B1 B0]
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with B0 ≡
U˜ 0
U˜ U
 where U˜ and U are those covariates (with U˜ including T when not adjusting µ for
T ) excluded from the baseline and change models (respectively), and Θ ≡ [Θ1 Θ0]T where Θ0 is a vector
of coefficients corresponding to those covariates excluded from the model. We can then apply a modified
version of the familiar omitted-variable bias result:20
Theorem 1. Suppose Y ∼N(ABΘ,Σ), where B is a matrix and Θ is a vector, each which can be parti-
tioned into [B1 B0] and [Θ1 Θ0]
T respectively, and A is a matrix of conforming dimension. Suppose Y is
modeled as Y ∼N(AB1Θ1,Σ). Finally, let Θ1 have a flat prior. Then, the bias of Θ̂1 as estimated by the
model is
EY |Θ[Θ̂1 −Θ1] = (B1TATΣ−1AB1)−1B1TATΣ−1AB0Θ0.
A proof is available in Appendix A. While the bias of ∆ can be obtained from Theorem 1, it is difficult
to isolate and express it in a simple closed form. Appendix A also describes two simulations which compute
empirical means of the bias result when the baseline and change models are adjusted for the same covariates
(Xw˜=1 = Xw=1). The first simulation shows that when the baseline model is not adjusted for T , the
estimation of ∆ is only unbiased when the covariate sets are {X1,X2,X3} from Table 1. The second
simulation does adjust the baseline model for T , and shows that the estimation of ∆ is unbiased when the
covariates sets are {X1,X3}. As X2 is a static confounder (see Table 1), an important consequence is that
the baseline model must be adjusted for T to avoid bias due to unobserved static confounders.
2.4 Variable-by-variable simulations
To isolate the impact of each combination of does/does not affect T , does/does not affect µ, and does/does
not affect µdiff has on the estimation of ∆, for various modeling choices, we conduct a simulation. We
define eight data generation scenarios by the process described in Section 2.2; each scenario uses only one of
the covariates described in Table 1 as the single true generating covariate and (depending on the modeling
choice) the single model covariate. Then, we estimate ∆ according to each of the following eight model
choices:
• Choice 1: Do not adjust µ or µdiff for Xk.
• Choice 2: Adjust µ, but do not adjust µdiff, for Xk.
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• Choice 3: Adjust µdiff, but do not adjust µ, for Xk.
• Choice 4: Adjust µ and µdiff for Xk.
• Choice 5: Adjust µ for T , do not adjust µdiff for Xk.
• Choice 6: Adjust µ for T and Xk, but do not adjust µdiff, for Xk.
• Choice 7: Adjust µ for T , adjust µdiff for Xk.
• Choice 8: Adjust µ for T and Xk, adjust µdiff for Xk.
Table 2 displays the bias, mean squared error (MSE), and coverage rates of ∆̂ for each data-generating
covariate Xk under each scenario, with 5000 replications. Bolded quantities indicate optimal values; that is,
estimated biases within a margin of error from 0, lowest MSEs within a margin of error of each other, and
coverage rates no more than a margin of error less than 0.95. From these results, we can make the following
conclusions:
• Estimation of ∆ is biased when we fail to adjust µdiff for covariates predictive of T and µdiff (here,
Choices 1, 2, 5, and 6 in the X1 and X3 panels).
• Choices 3, 4, and 8 always lead to unbiased estimation of ∆ (however, these all require that we observe
the covariate Xk).
• Estimates of ∆ are biased when we do not adjust µ for covariates predictive of T and µ (here, Choice
1 in the X2 panel). This bias disappears when we include T as a predictor for µ (Choices 5 and 6).
However, adjusting µdiff for covariates predictive of µ and T (here, X1 and X3) without adjusting µ
for those Xk (Choice 7) leads to biased estimates of ∆.
• The most efficient model (by lowest-MSE criterion) varies across covariate cases; in some cases only µ
should be adjusted, in some only µdiff should be adjusted, in some they should both be adjusted, and
in others adjusting either needlessly complicates the model.
• Choices that yield unbiased estimates of ∆ have nominal coverage rates, while those with bias do not.
In Table 2, when there are covariates predictive of both µ and T (here, X1 and X2), the bias of ∆̂ is
decreased when T is included as a predictor for µ (Choice 1, Choice 5). However, when such a covariate is
excluded from µ, T is retained as a predictor for µ, and the covariate is included for µdiff (Choice 7), there
is noticeable bias. To avoid this bias, one could force the baseline and change models to include the same
predictors. Another approach to avoid this bias would instead be to include those Xk in the change model
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that are predictive of T and µdiff, and then only include those Xk in the baseline model that are predictive
of T , µdiff, and µ.
Variable selection should also be concerned with efficient estimation. When there are covariates predictive
of µ but not µdiff (here, X2 and X6), bias and MSE are minimized when Xk is included in the model for µ
but not µdiff (Choices 2 and 6). When there are covariates predictive of µdiff but not µ (here, X3 and X7),
MSE is minimized when Xk is included in the model for µ
diff regardless of the baseline model adjustment
(Choices 3, 4, 7, and 8). One approach to variable selection, then, is to perform variable selection on the
baseline and change models separately. To arrive at a more parsimonious (i.e., fewer covariates used) model,
another alternative approach is to include any Xk predictive of µ
diff in the change model, and only include
any Xk predictive of µ and µ
diff in the baseline model.
3 Variable selection approaches
Motivated by the results in Section 2, we propose four variable selection approaches using the Bayesian
spike-and-slab prior in (4). The slab component of this prior is not limited to be Gaussian. In fact, Ghosh et
al. recommend a central t-distribution, which has good support for values of βk moderately far from 0, but
unlike a Gaussian distribution it has heavier tails to support values of βk very far from 0.
21 To implement
this, we modify Equation (4) to
βk|wk, z2k, λk ∼ (1− wk)N(0, z2k) + wktν(0, λk),
wk|p ∼ Bernoulli(p), k = 1, ...,K,
(7)
where tν(0, λk) denotes the central Student t-distribution with ν degrees of freedom and scale λk.
To facilitate computation, we can take advantage of the t-distribution’s equivalence with a scale mixture
of Gaussian distributions, re-expressing Equation (7) as
βk|wk, z2k, γk ∼ (1− wk)N(0, z2k) + wkN(0, 1/γk),
γk|λk ∼ Gamma(shape = ν/2, rate = (ν/2)λ2k)
wk|p ∼ Bernoulli(p), k = 1, ...,K,
(8)
with a diffuse mean-zero Gaussian prior for the intercepts β˜0 and β0: pi(β˜0) = N(0, ω˜
2) and pi(β0) = N(0, ω
2),
where ω˜2 and ω2 are set to large constants. We now propose four applications of the spike-and-slab prior in
Equation (7) to perform variable selection in the DiD context. Appendix B gives the precise Gibbs sampling
algorithm for each method.
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3.1 Separate method
The first approach we consider, called the Separate method, performs variable selection separately for the
baseline and change models. That is, the posterior of β˜k informs whether or not to include Xk in the model
for µ, and the posterior of βk independently informs whether or not to include Xk in the model for µ
diff.
This approach makes sense when there are some candidate variables related to either the baseline or change
models, but perhaps not both. Using this method, the priors for β˜k and βk are
β˜k|w˜k, λ˜k ∼ (1− w˜k)N(0, z2k) + w˜ktν(0, λ˜k), k = 1, ...,K
βk|wk, λk ∼ (1− wk)N(0, z2k) + wktν(0, λk), k = 1, ...,K
(9)
where w˜k is 1 if Xk is included in the baseline model and 0 otherwise, and wk is 1 if Xk is included in the
change model and 0 otherwise. We can re-express (9) as a multivariate Gaussian distribution using the scale
mixture definition of the t-distribution in (8). Specifically, we define ak = 1/
√
γk when wk = 1 and ak = zk
if wk = 0. Then, the prior for β arises as β ∼ N(0,D2), where D ≡ diag(ω, a1, ..., aK). The setup for β˜ is
analogous: β˜ ∼N(0, D˜2).
3.2 Shared method
While the Separate method makes sense when variables are clearly related to either the baseline model or
the change model (but not both), there may be scenarios in which some covariates are predictive of both.
For example, consider a county-level initiative to encourage its residents to recycle more. If the average
socioeconomic status of the county were positively related to baseline per-capita pounds recycled, one would
want to include the county’s socioeconomic status as a covariate in the baseline model. If residents with
higher socioeconomic status were also more willing to change their recycling habits, one would also want
to include socioeconomic status in the change model. In this instance, the Separate method would use the
posterior masses of β˜k and βk separately to make independent draws for w˜k and wk, where the optimal
approach in this instance would be to use information from both posteriors to strengthen the probability of
including a covariate that should be included in both models.
The second approach, which we call the Shared method, is to constrain Xk to be either excluded or
included in both models based on the joint posterior distributions of β˜k and βk. We specify a joint prior for
[β˜k βk]
T with a shared inclusion indicator wk:
[β˜k βk]
T | wk, λk ∼ (1− wk)N2(0, z2kI2) + wktν(0, λkI2), k = 1, ...K (10)
11
where tν is a bivariate t-distribution with ν degrees of freedom.
3.3 Sufficient method
The Separate and Shared methods provide approaches which include Xk if there is statistical evidence that
Xk reduces the residual variance in µ and/or µ
diff. These approaches are especially sensible when the
number of groups J is small, wherein inference on ∆ heavily depends on which covariates are included in
the models. Suppose instead that the number of groups J is large, so that estimates of ∆ are relatively
precise. In this scenario, the only covariates that need to be included to estimate ∆ without bias are those
related to both T and µdiff. For example, Table 2 suggests that when we adjust the baseline model for T
(Choices 5-8), the minimally sufficient set of covariates needed to estimate ∆ without bias are {X1,X3}.
We propose a third method, which we call the Sufficient method, to identify the smallest model that allows
unbiased estimation of ∆.
First, we introduce an exposure-confounder model to identify those Xk that are associated with T . If
T is binary, this may be a probit or logistic model. If instead T is continuous, a reasonable exposure model
may be
T = Xα+ α, α ∼N(0, σ2αI) (11)
with a noninformative prior on σ2α: pi(σ
2
α) ∝ 1/σ2α. Then, we can impose a similar spike-and-slab prior on
each αk:
αk|wek, λek ∼ (1− wek)N(0, zek) + wektν(0, λek)
with pi(wek) = Bern(p
e), where wek = 1 when Xk is selected for this exposure model and is 0 otherwise.
To only include those covariates for µdiff that are also predictive of T , we set wk = 0 if w
e
k = 0; that is,
pi(wk) = w
e
k ∗ Bern(p). Similarly, to only include those covariates for µ that are also predictive of µ, µdiff,
and T , we only allow w˜k to be 1 when wk = 1: pi(w˜k) = wk ∗ Bern(p˜).
Given the exposure model in (11) and outcome model in (6), estimation of the treatment effect usually
proceeds by first estimating α using the exposure model, treating estimates of α as fixed and known, and
then estimating ∆ using the outcome model. An alternative fully multivariate approach is to combine (11)
and (6) into one joint likelihood and model both simultaneously in a Bayesian framework. However, Zigler
et al. show that such an approach can lead to “feedback” between the two models; that is, quantities in the
outcome model informing quantities in the exposure model.22 In general, model feedback can lead to biased
estimates of the treatment effect. To prevent this, we choose to perform variable selection sequentially across
the exposure, change, and baseline models. Specifically, within each Gibbs iteration, we draw wek without
12
conditioning on the baseline or change models, and we draw wk without conditioning on the baseline model.
3.4 Efficient method
Table 2 suggests that the most efficient estimates of ∆, in terms of MSE, occur when the covariate set
includes those Xk related to µ
diff and excludes those Xk that are not. Combining this with the desire for
model parsimony, we blend the Separate and Sufficient methods to include only those Xk related to µ
diff.
To start, we use the same spike-and-slab prior as in Equation (9) and do not fit an exposure model. Since
the decision to include Xk in the model for µ
diff depends on whether Xk predicts T , we assign a prior for
wk that is independent of the exposure model: pi(wk) = Bern(p). When selecting covariates for the baseline,
it suffices to consider only those that are also predictive of change, so we only allow w˜k to be 1 when wk = 1:
pi(w˜k) = wk ∗Bern(p˜). Again to prevent model feedback, we draw wk without conditioning on the model for
baseline.
4 Simulations to assess variable selection algorithms
We conducted a simulation study to assess bias, MSE, and coverage rates of ∆ when implementing the
Separate, Shared, Sufficient, and Efficient methods using the covariate set in Section 2.1 and data generation
scheme described in Section 2.2, with α = [1, 1, 1, 1, 0, 0, 0, 0], β˜ = [1, 1, 0, 0, 1, 1, 0, 0], β = [1, 0, 1, 0, 1, 0, 1, 0],
∆˜ = 0, and ∆ = 1.
For the slab, we chose a t-distribution with ν = 5 degrees of freedom and λk = 5, which has regression
coefficients moderately far from 0, and has thick tails to support β very far from 0. To allow for conditionally
conjugate Gibbs sampling, we re-expressed the slabs for β˜k and βk in (9) as N(0, 1/γ˜k) and N(0, 1/γk), with
weakly informative Gamma(shape = 5/2, rate = (5/2) ∗ 52) priors for each γ˜k and γk. Finally, we chose a
spike variance of z2k = 0.01
2, prior inclusion probabilities p˜ = p = pe = 1/2, and prior variance for the
intercept coefficients ω˜2 = ω2 = 10000.
In the Shared approach, we again took advantage of the scale mixture of Gaussian distributions to
represent the t-distribution by re-expressing Equation (10) as
[β˜k βk]
T | wk, γk ∼ (1− wk)N2(0, 0.012I2) + wkN2(0, 1/γkI2), k = 1, ...K
with pi(γ1) = ... = pi(γK) = Gamma(5/2, (5/2) ∗ 52).
Tables 3-6 display, for number of groups J = 50 and J = 100, the bias, MSE, and coverage rates of ∆,
the mean number of predictors included in the change and baseline models, and the inclusion probabilities
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for each predictor. The results are presented for each variable selection algorithm with the results using the
“Full” model (with covariates {X1, ...,X8} for µ and µdiff) and the “Null” model (with no covariates for
either model). Overall, the Separate and Efficient methods performed the best in terms of bias and MSE.
The Sufficient method suffered higher bias and MSE with lower coverage; a brief investigation showed that
this was due to uncertainty in the variable selection for the exposure model. The Null model performed
poorly, having the highest bias and MSE with unacceptably low coverage. While ∆ˆ as estimated by the Full
model was unbiased, it had higher MSE than the methods with variable selection in almost every scenario.
The Shared method included the most predictors for µdiff, while the Sufficient method yielded the most
parsimonious model for µdiff. Tables 4 and 6 show that the inclusion probabilities behave as desired using
each method. Specifically, the Separate and Efficient methods included covariates that were predictive of
µdiff often, the Shared method included covariates that were predictive µdiff or µ often, and the Sufficient
method only included those covariates that were predictive of µdiff and T often. The bias and MSE (with
their margins of error) decreased as J increased from 50 to 100, suggesting that each variable selection
method leads to consistent estimation of ∆. Similarly, the inclusion probabilities approached either 0 or 1 as
J increased, suggesting that the Separate, Sufficient, and Efficient methods are consistent in including the
variables that they are designed to select. The Shared method tended to include a variable in both models
if it is predictive of either baseline (β˜k) or change (βk).
5 Application to primary care redesign and diabetes data
Diabetes mellitus is a chronic condition that impacts the way the body breaks down glucose, its main
source of energy. Diabetes can negatively impact one’s endocrine, excretory, digestive, kidney, circulatory,
integumentary, central nervous, and reproductive systems.23 To identify trends in a diabetes patient’s blood
sugar levels, the American Diabetes Association recommends routine A1c tests and consultations with their
primary care physician.24 Primary care practices provide a structured system for individuals to manage
their diabetes.25,26 In 2008, the Minnesota State Legislature endorsed the Patient Centered Medical Home
(PCMH) as the preferred model for primary care redesign.27
The MN Community Measurement (MNCM) Optimal Diabetes Care dataset contains patient-level sum-
maries of how a patient at a participating clinic managed her diabetes in a given year. It contains a patient’s
latest A1c, low-density lipoprotein (LDL), and systolic blood pressure (SBP) measurements for the year, as
well as information on whether or not a patient is diagnosed with ischemic vascular disease (IVD), whether
they have type 1 diabetes or not (Type 1), whether they have private insurance or not (Commercial), and
whether or not they use tobacco (Tobacco). The American Community Survey (ACS) is an annual survey
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conducted by the U.S. Census Bureau which administers a questionnaire to a sample of addresses capturing
many of the variables included in the long form decennial census. It contains metrics of the socioeconomic
statuses of a patient’s neighborhood which we used to compute composite measures of “Wealth” and “In-
come” and matched to the patient record at the ZIP code level.28
The Physician Practice Connections-Research Survey29 is a survey designed to measure primary care
organizational infrastructure across five of the six domains of Bodenheimer and Wagner’s Chronic Care
Model (CCM):30 health care organization, delivery system redesign, clinical information systems, decision
support, and self-management support. Clinics in Minnesota were asked to report organizational structure
at present (2011) and (by recall) in 2008. The PPCRS was administered a second time in 2017 to a practice
population including the original health care home cohort. We identified one principal component31 driving
the variance in the 2008 and 2017 PPCRS results, so we define a clinic’s “score” as the first principal
component of the survey matrix. To measure how a clinic matured in its primary care delivery from 2008
to 2017, we define our main exposure of interest as the clinic score difference: cdiff ≡ c(2017) − c(2008).
Clustering analysis and a histogram of cdiff implied that the higher a clinic’s clinic score is, the more mature
it is in its primary care transformation toward a PCMH.
In this section, we use outcome and demographic patient data from MNCM, neighborhood-level covariates
from the ACS, and clinic resources and services survey data from the Physician Practice Connections-
Research Survey to quantify the causal impact of primary care redesign on mean diabetes outcomes from
the year 2008 (pre-treatment) to the year 2017 (post-treatment) on J = 96 clinics. Specifically, for each
outcome separately, we fit the HDiD model in (6) and apply each of the four variable selection techniques
introduced in Section 3. Each candidate predictor is a change in proportions or means from 2008 to 2017;
for example, the “Age” predictor for clinic j is its mean patient age in 2008 subtracted from its mean patient
age in 2017. In general, one should not adjust these models for post-treatment covariates that are affected
by the treatment (that is, those Xk such that T → Xk → µdiff). Fortunately, this is not a concern in
our context. There is little contextual evidence to suggest that a clinic’s speed to adopt the PCMH model
affects clinic-level demographic changes. The choice to adopt the PCMH model has a small or nonexistent
effect on a patient’s choice of clinic, a choice probably based more on static variables such as the patient’s
geographic location and insurance type. For each method, we use a spike standard deviation of zk = 0.025
for each candidate predictor.
Table 7 displays the inclusion probabilities within the change model for each candidate predictor and
outcome. Change in percent of Female patients seems to be predictive of baseline A1c and LDL but not
change in A1c or LDL, evidenced by the starkly different inclusion probabilities between the Shared methdods
and the others. Change in percent of patients with IVD is a strong predictor of change in LDL, though must
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not be a strong predictor of cdiff, seen in the differences in inclusion probabilities between the Sufficient and
Separate, Shared, and Efficient methods. There does not appear to be much evidence that baseline clinic
score c(2008) is predictive of change in A1c, LDL, or SBP.
Tables 8-10 display, using each variable selection method and fitting the full model, the 95% credible
intervals for β with the A1c, LDL, and SBP outcomes (respectively). Overall, the variable selection methods
led to similar estimates for cdiff, a sensible result given the large number of clinics J and that all methods are
designed to give unbiased estimates of the treatment effect. All credible intervals for the A1c outcome contain
0. The main exposure of interest, cdiff is significantly negatively associated with the µdiff for the LDL and
SBP outcomes, suggesting that greater strides in PCMH redesign lower diabetes patients’ cholesterol and
blood pressure. The only other significant dynamic predictor is change in proportion of patients with IVD
for the change in LDL outcome, suggesting that clinics who gained more (or retained fewer) patients with
IVD from 2009 to 2017 saw the average LDL of their patients decrease.
6 Conclusions and future directions
In this work, we introduced a hierarchical extension of the difference-in-differences model and suggested
variable selection methods therein. We showed that estimation of the treatment effect is biased if we do not
adjust a baseline model either for the treatment, or for all covariates predictive of both the treatment and
baseline. We then showed that in order to estimate the treatment effect without bias, we also need to adjust
the change model for all covariates that jointly affect both the treatment and change in outcome. Covariates
that are correlated with the change in means should also be included in the model for change to achieve
more precise estimates of the treatment effect.
With these guidelines in place, we presented four Bayesian variable selection techniques that can be
implemented in the HDiD framework. Just as in our application in Section 5, such methods are useful when
subjects cannot be matched from pre- to post-treatment timepoints and when the treatment is administered
at the group level. Through simulation, we found that each approach leads to reasonable estimation of the
treatment effect, and the results suggest that the approaches are asymptotically unbiased. Our simulations
suggested that the Sufficient method leads to the smallest covariate set able to estimate the treatment
effect without bias (asymptotically), while the Efficient method estimates the treatment effect without bias
(asymptotically) and with the lowest variance. We applied these methods and show that as a clinic matures
in its transformation as a patient-centered medical home, the average LDL and SBP of its patients decrease.
In this paper, we do not consider the consequences of adjusting for post-treatment covariates whose values
are affected by the treatment (that is, those Xk such that T →Xk → µdiff), which is extensively cautioned
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against in the literature.32,33 We do not recommend applying our variable selection algorithms using such
covariates. Our model explicitly assumes a homogeneous treatment effect across treatment groups; this
differs from the typical DiD setting in which the primary estimand of interest is the average treatment effect
on the treated.34
Our current approaches assume a somewhat strict prior correlation structure between the inclusion indi-
cators. Specifically, the Separate method assumes a priori that the inclusion indicators for the baseline and
change model are uncorrelated, while the Shared method forces the two to be identical. The Sufficient and
Efficient methods induce correlation by forcing a covariate excluded from the change model to be excluded
from the baseline model. Models that allow for a more flexible dependence structure between the baseline
and change models are a direction of future research.
Software
The codes to perform the simulation in Section 2.4 and the variable selection algorithms in Section 3 are
available on Github: https://github.com/JamesNormington/VS_in_HDiD.
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X1 X2 X3 X4 X5 X6 X7 X8
T X X X X
µ X X X X
µdiff X X X X
Table 1: Role of each covariate in the causal graph
Figure 1: Assumed causal relationships and data generation throughout the paper
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Choice Bias MSE Coverage Choice Bias MSE Coverage
X1 X5
Choice 1 0.528 0.297 0.038 Choice 1 −0.003 0.048 0.949
Choice 2 0.500 0.260 0.050 Choice 2 0.002 0.045 0.951
Choice 3 0.000 0.025 0.955 Choice 3 0.000 0.025 0.954
Choice 4 0.000 0.026 0.951 Choice 4 0.000 0.026 0.952
Choice 5 0.502 0.269 0.054 Choice 5 0.002 0.046 0.956
Choice 6 0.499 0.267 0.051 Choice 6 −0.002 0.046 0.949
Choice 7 -0.041 0.028 0.943 Choice 7 −0.001 0.026 0.951
Choice 8 0.001 0.025 0.948 Choice 8 0.001 0.025 0.949
X2 X6
Choice 1 0.029 0.013 0.935 Choice 1 −0.003 0.025 0.946
Choice 2 0.002 0.013 0.952 Choice 2 0.001 0.024 0.955
Choice 3 0.000 0.025 0.955 Choice 3 0.000 0.025 0.955
Choice 4 0.000 0.026 0.951 Choice 4 0.000 0.026 0.952
Choice 5 0.001 0.013 0.952 Choice 5 −0.004 0.025 0.946
Choice 6 −0.001 0.013 0.953 Choice 6 −0.001 0.025 0.950
Choice 7 -0.041 0.028 0.943 Choice 7 −0.001 0.026 0.951
Choice 8 0.001 0.025 0.948 Choice 8 0.001 0.025 0.949
X3 X7
Choice 1 0.499 0.267 0.049 Choice 1 0.002 0.046 0.953
Choice 2 0.500 0.267 0.050 Choice 2 0.002 0.045 0.951
Choice 3 0.000 0.025 0.954 Choice 3 0.000 0.025 0.954
Choice 4 0.000 0.026 0.951 Choice 4 0.000 0.026 0.952
Choice 5 0.502 0.269 0.050 Choice 5 0.002 0.046 0.951
Choice 6 0.499 0.267 0.051 Choice 6 −0.002 0.046 0.949
Choice 7 −0.001 0.026 0.952 Choice 7 −0.001 0.026 0.951
Choice 8 0.001 0.025 0.948 Choice 8 0.001 0.025 0.949
X4 X8
Choice 1 −0.001 0.013 0.949 Choice 1 −0.003 0.025 0.947
Choice 2 0.002 0.013 0.952 Choice 2 0.001 0.024 0.955
Choice 3 0.000 0.025 0.954 Choice 3 0.000 0.025 0.954
Choice 4 0.000 0.026 0.951 Choice 4 0.000 0.026 0.952
Choice 5 0.002 0.012 0.952 Choice 5 0.000 0.025 0.954
Choice 6 −0.001 0.013 0.953 Choice 6 −0.001 0.025 0.950
Choice 7 −0.001 0.026 0.952 Choice 7 −0.001 0.026 0.951
Choice 8 0.001 0.025 0.948 Choice 8 0.001 0.025 0.949
Table 2: Bias, MSE, and Coverage of ∆̂. Bolded quantities indicate optimal values.
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Full Separate Shared Sufficient Efficient Null
Bias -0.002 (±0.005) 0.025 (±0.004) 0.031 (±0.004) 0.126 (±0.006) 0.022 (±0.004) 0.407 (±0.004)
MSE 0.029 (±0.001) 0.018 (±0.001) 0.024 (±0.001) 0.059 (±0.002) 0.017 (±0.001) 0.185 (±0.003)
Coverage 0.948 0.949 0.941 0.876 0.937 0.180
Predictors included (µdiff) 8 4.12 (±0.01) 5.78 (±0.01) 1.69 (±0.01) 4.13 (±0.01) 0
Predictors included (µ) 8 4.15 (±0.01) 5.78 (±0.01) 0.52 (±0.01) 1.75 (±0.01) 0
Table 3: Bias, MSE, and coverage rates (with Margin of Error) of ∆̂ using the model with all predictors
(Full), each variable selection method, and the model with no predictors (Null), each with their mean number
of predictors included, with J = 50 groups
X1 X2 X3 X4 X5 X6 X7 X8
βk 1 0 1 0 1 0 1 0
β˜k 1 1 0 0 1 1 0 0
αk 1 1 1 1 0 0 0 0
Separate 0.929 0.085 0.934 0.085 0.984 0.062 0.984 0.059
Shared 0.993 0.901 0.876 0.063 1.000 0.969 0.958 0.023
Sufficient 0.695 0.139 0.681 0.141 0.012 0.003 0.012 0.003
Efficient 0.936 0.085 0.932 0.086 0.986 0.064 0.984 0.059
Table 4: Inclusion probabilities of X1, ...,X8 in the model for µ
diff using each method with corresponding
true values of β, β˜,α, with J = 50 groups
Full Separate Shared Sufficient Efficient Null
Bias 0.003 (±0.003) 0.003 (±0.002) 0.004 (±0.002) 0.008 (±0.003) 0.000 (±0.002) 0.410 (±0.003)
MSE 0.014 (±0.001) 0.005 (±0.000) 0.008 (±0.000) 0.011 (±0.001) 0.005 (±0.000) 0.177 (±0.002)
Coverage 0.947 0.958 0.953 0.954 0.958 0.017
Predictors included (µdiff) 8 4.18 (±0.00) 6.02 (±0.00) 2.14 (±0.00) 4.18 (±0.00) 0
Predictors included (µ) 8 4.17 (±0.00) 6.02 (±0.00) 1.04 (±0.01) 2.20 (±0.01) 0
Table 5: Bias, MSE, and coverage rates (with Margin of Error) of ∆̂ using the model with all predictors
(Full), each variable selection method, and the model with no predictors (Null), each with their mean number
of predictors included, with J = 100 groups
X1 X2 X3 X4 X5 X6 X7 X8
βk 1 0 1 0 1 0 1 0
β˜k 1 1 0 0 1 1 0 0
αk 1 1 1 1 0 0 0 0
Separate 0.998 0.051 0.998 0.052 1.000 0.040 1.000 0.041
Shared 1.000 0.995 0.991 0.021 1.000 1.000 1.000 0.009
Sufficient 0.975 0.071 0.970 0.071 0.025 0.001 0.023 0.001
Efficient 0.999 0.052 0.998 0.052 1.000 0.042 1.000 0.041
Table 6: Inclusion probabilities of X1, ...,X8 in the model for µ
diff using each method with corresponding
true values of β, β˜,α, with J = 100 groups
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Age Female IVD Type 1 Commercial Tobacco Wealth Income c(2008)
A1c
Separate 0.021 0.031 0.337 0.061 0.027 0.104 0.035 0.063 0.008
Shared 0.001 0.978 0.156 0.004 0.001 0.030 0.003 0.003 0.000
Sufficient 0.003 0.008 0.033 0.041 0.014 0.033 0.007 0.003 0.009
Efficient 0.017 0.027 0.282 0.071 0.030 0.106 0.036 0.041 0.008
LDL
Separate 0.430 0.128 1.000 0.324 0.033 0.139 0.053 0.119 0.018
Shared 0.529 0.956 1.000 0.337 0.003 0.050 0.001 0.002 0.001
Sufficient 0.013 0.010 0.054 0.244 0.016 0.084 0.007 0.006 0.053
Efficient 0.674 0.043 1.000 0.158 0.033 0.130 0.055 0.098 0.019
SBP
Separate 0.145 0.044 0.561 0.092 0.037 0.115 0.023 0.046 0.010
Shared 0.066 0.002 0.109 0.012 0.002 0.020 0.001 0.001 0.000
Sufficient 0.017 0.008 0.046 0.053 0.020 0.039 0.006 0.004 0.011
Efficient 0.127 0.039 0.579 0.092 0.038 0.101 0.027 0.044 0.010
Table 7: Inclusion probabilities for each candidate variable in the change model
Separate Shared Sufficient Efficient Full
cdiff (∆) (-0.02, 0.03) (-0.02, 0.03) (-0.02, 0.03) (-0.02, 0.03) (-0.01, 0.05)
Age (-0.06, 0.04) (-0.05, 0.04) (-0.05, 0.04) (-0.05, 0.04) (-0.24, 0.11)
Female (-0.05, 0.06) (-0.16, 0.34) (-0.05, 0.05) (-0.06, 0.05) (-0.24, 0.30)
IVD (-0.82, 0.04) (-0.86, 0.04) (-0.07, 0.043) (-0.82, 0.04) (-0.96, 0.01)
Type 1 (-0.05, 0.24) (-0.05, 0.05) (-0.05, 0.10) (-0.05, 0.33) -(0.18, 1.10)
Commercial (-0.06, 0.04) (-0.05, 0.04) (-0.06, 0.04) (-0.07, 0.04) (-0.25, 0.14)
Tobacco (-0.05, 0.56) (-0.05, 0.62) (-0.05, 0.07) (-0.05, 0.53) (-0.55, 0.85)
Wealth (-0.07, 0.04) (-0.06, 0.04) (-0.06, 0.04) (-0.08, 0.04) (-0.24, 0.12)
Income (-0.13, 0.03) (-0.06, 0.03) (-0.06, 0.03) (-0.09, 0.03) (-0.22, 0.06)
c(2008) (-0.01, 0.05) (-0.01, 0.04) (-0.01, 0.05) (-0.01, 0.05) (-0.02, 0.05)
Table 8: 95% credible intervals for ∆ and β using each variable selection method, A1c
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Separate Shared Sufficient Efficient Full
cdiff (∆) (-0.07, -0.00) (-0.07, -0.01) (-0.09, -0.01) (-0.07, -0.00) (-0.06, 0.02)
Age (-0.03, 0.54) (-0.01, 0.67) (-0.04, 0.06) (-0.02, 0.53) (0.25, 0.73)
Female (-0.04, 0.51) (-0.04, 0.71) (-0.05, 0.05) (-0.05, 0.11) (0.01, 0.69)
IVD (-2.38, -1.04) (-2.43, -1.16) (-1.57, 0.04) (-2.34, -1.06) (-2.23, -0.93)
Type 1 (-1.45, 0.05) (-1.52, .05) (-1.52, 0.04) (-1.06, 0.06) (-0.76, 1.03)
Commercial (-0.05, 0.06) (-0.05, 0.05) (-0.05, 0.05) (-0.05, 0.06) (-0.04, 0.61)
Tobacco (-0.05, 1.02) (-0.05, 1.14) (-0.05, 1.18) (-0.06, 0.82) (-0.04, 1.82)
Wealth (-0.17, 0.04) (-0.06, 0.04) (-0.06, 0.04) (-0.17, 0.04) (-0.32, 0.17)
Income (-0.25, 0.03) (-0.06, 0.03) (-0.06, 0.04) (-0.22, 0.03) (-0.33, 0.06)
c(2008) (-0.01, 0.06) (-0.01, 0.06) (-0.00, 0.09) (-0.01, 0.06) (0.00, 0.10)
Table 9: 95% credible intervals for ∆ and β using each variable selection method, LDL
Separate Shared Sufficient Efficient Full
cdiff (∆) (-0.09, -0.02) (-0.09, -0.02) (-0.09, -0.02) (-0.09, -0.02) (-0.11, -0.03)
Age (-0.04, 0.35) (-0.04, 0.34) (-0.04, 0.06) (-0.04, 0.34) (0.07, 0.59)
Female (-0.05, 0.10) (-0.05, 0.05) (-0.05, 0.05) (-0.05, 0.12) (-0.05, 0.68)
IVD (-0.04, 1.36) (-0.04, 0.95) (-0.04, 0.75) (-0.04, 1.34) (0.04, 1.44)
Type 1 (-0.50, 0.07) (-0.05, 0.05) (-0.24, 0.06) (-0.50, 0.07) (-0.96, 0.99)
Commercial (-0.05, 0.09) (-0.05, 0.05) (-0.05, 0.06) (-0.05, 0.08) (-0.22, 0.49)
Tobacco (-0.68, 0.06) (-0.08, 0.05) (-0.38, 0.05) (-0.700, 0.06) (-1.03, 0.94)
Wealth (-0.05, 0.06) (-0.05, 0.05) (-0.05, 0.05) (-0.05, 0.06) (-0.21, 0.31)
Income (-0.04, 0.13) (-0.04, 0.06) (-0.04, 0.06) (-0.04, 0.12) (-0.11, 0.30)
c(2008) (-0.05, 0.02) (-0.05, 0.02) (-0.05, 0.02) (-0.05, 0.02) (-0.08, 0.02)
Table 10: 95% credible intervals for ∆ and β using each variable selection method, SBP
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A Omitted variable bias: derivation and a simulation
Here, we expand on the technical details behind the omitted-variable bias result from Section 2.3. Recall
our main result:
Theorem 1. Suppose Y ∼N(ABΘ,Σ), where B is a matrix and Θ is a vector, each which can be parti-
tioned into [B1 B0] and [Θ1 Θ0]
T respectively. Suppose Y is modeled as Y ∼N(AB1Θ1,Σ). Finally, let
Θ1 have a flat prior. Then, the bias of Θ̂1 as estimated by the model is
EY |Θ[Θ̂1 −Θ1] = (B1TATΣ−1AB1)−1B1TATΣ−1AB0Θ0.
The proof of the result is straightforward. The posterior distribution of Θ̂1 is
p(Θ̂1|Y ) = N(V B1TATΣ−1Y ,V ), where V ≡ (B1TATΣ−1AB1)−1
Then, EY |Θ[Θ̂1 −Θ1]
= V B1
TATΣ−1EY |ΘY −Θ1
= V B1
TATΣ−1A(B1Θ1 +B0Θ0)−Θ1
= (B1
TATΣ−1AB1)−1B1TATΣ−1AB0Θ0 
In our context, Θ1 ≡ [β˜w˜=1 ∆˜1 βw=1 ∆]T ] and Θ0 ≡ [β˜w˜=0 ∆˜0 βw=0]T where ∆˜1 = ∆˜ when T is
included in the baseline model and 0 otherwise and ∆˜0 = ∆˜ when T is excluded from the baseline model
and 0 otherwise, Y ≡ [Y (0)11 , ..., Y (0)J,n(0)J , Y
(1)
11 , ..., Y
(1)
J,n
(1)
J
]T , A ≡
A0 0
0 A1
 where A0 and A1 are matrices
that assign pre- and post-treatment group-level predictors to the subjects with that group (respectively),
B1 ≡
Xw˜=1 T˜ 0 0
Xw˜=1 T˜ Xw=1 T
 such that Xw˜=1 and Xw=1 are those covariates that are included in the
baseline and change models (respectively) and T˜ = T when T is included in the baseline model and 0 when
it is not, B0 ≡
U˜ 0
U˜ U
 where U˜ and U are the covariates excluded from the baseline and change models,
respectively, and Σ ≡
Σ11 Σ12
Σ21 Σ22
, where Σ11 is a block diagonal matrix where the j’th block is a diagonal
matrix with σ˜j+ τ˜
2 on the diagonal and τ˜2 on the within-block off-diagonals, Σ12 and Σ21 are block diagonal
matrices with every element in each block being τ˜2, and Σ22 is a block diagonal matrix where the j’th block
is a diagonal matrix with σ2j + τ
2 + τ˜2 on the diagonal and τ2 + τ˜2 on the within-block off-diagonals.
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Isolating ∆ is difficult, so we perform a brief simulation to see which covariates we need to include when
we sequentially add predictors to both µ and µdiff, comparing the bias of ∆̂ when we (1) do not adjust
the baseline model for T , and (2) adjust the baseline model for T . The simulations proceed by, for each
iteration, generating data via Section 2.2 and computing the bias result above.
No adjust for T Adjust for T
Null 0.437 0.400
+ X1 0.271 0.250
+ X3 0.031 -0.001
+ X2 0.002 0.000
+ X5 0.000 0.002
+ X7 0.000 0.000
+ X6 0.000 0.000
+ X4 0.000 0.000
Full 0.000 0.000
Table A1: Bias of ∆̂ by including the current and all preceding rows as covariates for µ and µdiff, without
and with adjusting µ for T
Table A1 shows the results of this simulation, where each row correponds to the addition of a new
covariate into the baseline and change models and the columns correspond to whether or not we adjust µ for
T . As an example, the “+ X3” and “Adjust for T ” cell adjusts the model for µ and µ
diff with {T ,X1,X3}
as covariates. The results show, and consistent with Table 2, that when we do not adjust µ for T , we
must adjust µ for all covariates predictive of both µ and T and adjust µdiff for all covariates predictive of
both µdiff and T (here, {X1,X2,X3}) to achieve unbiasedness in estimating ∆. When we do adjust µ for
T , Tables 2 and A1 suggest that we only need to adjust for all covariates predictive of T and µdiff (here,
{X1,X3}) to acheive unbiasedness.
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B Gibbs algorithms for each variable selection method
This appendix outlines the Gibbs sampling algorithms used in the simulation studies outlined in Section 4.
Separate method
Initialize.
For iterations t = 2, ..., T ,
For clinics j = 1, ..., J ,
Draw µ
(t)
j ∼ N(
τ˜2,(t−1){σ2,(t−1)j n(0)j Y¯ (0)j. +σ˜2,(t−1)j n(1)j (Y¯ (1)j. −µdiff,(t−1)j )}+σ˜2,(t−1)j σ2,(t−1)j Xj β˜
(t−1)
τ˜2,(t−1)(n(0)j σ
2,(t−1)
j +n
(1)
j σ˜
2,(t−1))+σ˜2,(t−1)j σ
2,(t−1)
j
,
σ˜
2,(t−1)
j σ
2,(t−1)
j τ˜
2,(t−1)
τ˜2,(t−1)(n(0)j σ
2,(t−1)
j +n
(1)
j σ˜
2,(t−1)
j )+σ˜
2,(t−1)
j σ
2,(t−1)
j
)
Draw µ
diff,(t)
j ∼ N(
n
(1)
j τ
2,(t−1)(Y¯ (1)j. −µ(t)j )+σ2,(t−1)j Xjβ
n
(1)
j τ
2,(t−1)+σ2,(t−1)j
,
σ
2,(t−1)
j τ
2,(t−1)
n
(1)
j τ
2,(t−1)+σ2,(t−1)j
)
Draw σ˜
2,(t)
j ∼ IG(0.5n(0)j , 0.5
∑n(0)j
i=1 (Y
(0)
ji − µ(t)j )2)
Draw σ
2,(t)
j ∼ IG(0.5n(1)j , 0.5
∑n(1)j
i=1 (Y
(1)
ji − µ(t)j − µdiff,(t)j )2)
Draw τ˜2,(t) ∼ IG(0.5J, 0.5||µ(t) −Xβ˜(t−1)||2)
Draw τ2,(t) ∼ IG(0.5J, 0.5||µdiff,(t) −Xβ(t−1)||2)
Draw β˜
(t) ∼N({τ˜−2,(t)XTX + D˜−2}−1τ˜−2,(t)XTµ(t), {τ˜−2,(t)XTX + D˜−2}−1)
Draw β(t) ∼N({τ−2,(t)XTX +D−2}−1τ−2,(t)XTµdiff,(t), {τ−2,(t)XTX +D−2}−1)
For candidate variables k = 1, ... K,
Draw w˜
(t)
k ∼ Bern( 11+B˜Fk ), with B˜F k =
N(β˜
(t)
k |0,0.12)
N(β˜
(t)
k |0,1/γ˜
(t)
k )
Draw w
(t)
k ∼ Bern( 11+BFk ), where BFk =
N(β
(t)
k |0,0.12)
N(β
(t)
k |0,1/γ
(t)
k )
Update D˜ and D based on the new draws for w˜ and w.
Draw γ˜
2,(t)
k ∼ IG(2.5 + 0.5w˜(t)k , 2.5 ∗ 52 + 0.5w˜(t)k β˜2,(t)k )
Draw γ
2,(t)
k ∼ IG(2.5 + 0.5w(t)k , 2.5 ∗ 52 + 0.5w(t)k β2,(t)k )
Shared method
Initialize.
For iterations t = 2, ..., T ,
For clinics j = 1, ..., J ,
Draw µ
(t)
j ∼ N(
τ˜2,(t−1){σ2,(t−1)j n(0)j Y¯ (0)j. +σ˜2,(t−1)j n(1)j (Y¯ (1)j. −µdiff,(t−1)j )}+σ˜2,(t−1)j σ2,(t−1)j Xj β˜
(t−1)
τ˜2,(t−1)(n(0)j σ
2,(t−1)
j +n
(1)
j σ˜
2,(t−1))+σ˜2,(t−1)j σ
2,(t−1)
j
,
σ˜
2,(t−1)
j σ
2,(t−1)
j τ˜
2,(t−1)
τ˜2,(t−1)(n(0)j σ
2,(t−1)
j +n
(1)
j σ˜
2,(t−1)
j )+σ˜
2,(t−1)
j σ
2,(t−1)
j
)
Draw µ
diff,(t)
j ∼ N(
n
(1)
j τ
2,(t−1)(Y¯ (1)j. −µ(t)j )+σ2,(t−1)j Xjβ
n
(1)
j τ
2,(t−1)+σ2,(t−1)j
,
σ
2,(t−1)
j τ
2,(t−1)
n
(1)
j τ
2,(t−1)+σ2,(t−1)j
)
Draw σ˜
2,(t)
j ∼ IG(0.5n(0)j , 0.5
∑n(0)j
i=1 (Y
(0)
ji − µ(t)j )2)
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Draw σ
2,(t)
j ∼ IG(0.5n(1)j , 0.5
∑n(1)j
i=1 (Y
(1)
ji − µ(t)j − µdiff,(t)j )2)
Draw τ˜2,(t) ∼ IG(0.5J, 0.5||µ(t) −Xβ˜(t−1)||2)
Draw τ2,(t) ∼ IG(0.5J, 0.5||µdiff,(t) −Xβ(t−1)||2)
Draw β˜
(t) ∼N({τ˜−2,(t)XTX +D−2}−1τ˜−2,(t)XTµ(t), {τ˜−2,(t)XTX +D−2}−1)
Draw β(t) ∼N({τ−2,(t)XTX +D−2}−1τ−2,(t)XTµdiff,(t), {τ−2,(t)XTX +D−2}−1)
For candidate variables k=1, ..., K,
Draw w
(t)
k ∼ Bern( 11+BFk ), with BFk =
N2([β˜
(t)
k ,β
(t)
k ]
T |02,0.12I2)
N2([β˜
(t)
k ,β
(t)
k ]
T |02,1/γ˜(t)k I2)
Update D based on the new draw for w.
Draw γ
2,(t)
k ∼ IG(2.5 + 0.5w(t)k , 2.5 ∗ 52 + 0.5w(t)k (β˜2,(t)k + β2,(t)k ))
Sufficient method
Initialize.
For iterations t = 2, ..., T ,
For clinics j = 1, ..., J ,
Draw µ
(t)
j ∼ N(
τ˜2,(t−1){σ2,(t−1)j n(0)j Y¯ (0)j. +σ˜2,(t−1)j n(1)j (Y¯ (1)j. −µdiff,(t−1)j )}+σ˜2,(t−1)j σ2,(t−1)j Xj β˜
(t−1)
τ˜2,(t−1)(n(0)j σ
2,(t−1)
j +n
(1)
j σ˜
2,(t−1))+σ˜2,(t−1)j σ
2,(t−1)
j
,
σ˜
2,(t−1)
j σ
2,(t−1)
j τ˜
2,(t−1)
τ˜2,(t−1)(n(0)j σ
2,(t−1)
j +n
(1)
j σ˜
2,(t−1)
j )+σ˜
2,(t−1)
j σ
2,(t−1)
j
)
Draw µ
diff,(t)
j ∼ N(
n
(1)
j τ
2,(t−1)(Y¯ (1)j. −µ(t)j )+σ2,(t−1)j Xjβ
n
(1)
j τ
2,(t−1)+σ2,(t−1)j
,
σ
2,(t−1)
j τ
2,(t−1)
n
(1)
j τ
2,(t−1)+σ2,(t−1)j
)
Draw σ˜
2,(t)
j ∼ IG(0.5n(0)j , 0.5
∑n(0)j
i=1 (Y
(0)
ji − µ(t)j )2)
Draw σ
2,(t)
j ∼ IG(0.5n(1)j , 0.5
∑n(1)j
i=1 (Y
(1)
ji − µ(t)j − µdiff,(t)j )2)
Draw τ˜2,(t) ∼ IG(0.5J, 0.5||µ(t) −Xβ˜(t−1)||2)
Draw τ2,(t) ∼ IG(0.5J, 0.5||µdiff,(t) −Xβ(t−1)||2)
Draw β˜
(t) ∼N({τ˜−2,(t)XTX + D˜−2}−1τ˜−2,(t)XTµ(t), {τ˜−2,(t)XTX + D˜−2}−1)
Draw β(t) ∼N({τ−2,(t)XTX +D−2}−1τ−2,(t)XTµdiff,(t), {τ−2,(t)XTX +D−2}−1)
For candidate variables k = 1, ... K,
Draw wek ∼ Bern
(
1
1+BF ek
)
, where BF ek =
N(αk|0,0.12)
N(αk|0,1/γek)
Draw wk ∼ wek ∗ Bern
(
1
1+BFk
)
, where BFk =
N(βk|0,0.12)
N(βk|0,1/γk)
Draw w˜k ∼ wk ∗ Bern
(
1
1+B˜Fk
)
, where B˜F k =
N(β˜k|0,0.12)
N(β˜k|0,1/γ˜k)
Update D˜ and D based on the new draws for w˜ and w.
Draw γ˜
2,(t)
k ∼ IG(2.5 + 0.5w˜(t)k , 2.5 ∗ 52 + 0.5w˜(t)k β˜2,(t)k )
Draw γ
2,(t)
k ∼ IG(2.5 + 0.5w(t)k , 2.5 ∗ 52 + 0.5w(t)k β2,(t)k )
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Efficient method
Initialize.
For iterations t = 2, ..., T ,
For clinics j = 1, ..., J ,
Draw µ
(t)
j ∼ N(
τ˜2,(t−1){σ2,(t−1)j n(0)j Y¯ (0)j. +σ˜2,(t−1)j n(1)j (Y¯ (1)j. −µdiff,(t−1)j )}+σ˜2,(t−1)j σ2,(t−1)j Xj β˜
(t−1)
τ˜2,(t−1)(n(0)j σ
2,(t−1)
j +n
(1)
j σ˜
2,(t−1))+σ˜2,(t−1)j σ
2,(t−1)
j
,
σ˜
2,(t−1)
j σ
2,(t−1)
j τ˜
2,(t−1)
τ˜2,(t−1)(n(0)j σ
2,(t−1)
j +n
(1)
j σ˜
2,(t−1)
j )+σ˜
2,(t−1)
j σ
2,(t−1)
j
)
Draw µ
diff,(t)
j ∼ N(
n
(1)
j τ
2,(t−1)(Y¯ (1)j. −µ(t)j )+σ2,(t−1)j Xjβ
n
(1)
j τ
2,(t−1)+σ2,(t−1)j
,
σ
2,(t−1)
j τ
2,(t−1)
n
(1)
j τ
2,(t−1)+σ2,(t−1)j
)
Draw σ˜
2,(t)
j ∼ IG(0.5n(0)j , 0.5
∑n(0)j
i=1 (Y
(0)
ji − µ(t)j )2)
Draw σ
2,(t)
j ∼ IG(0.5n(1)j , 0.5
∑n(1)j
i=1 (Y
(1)
ji − µ(t)j − µdiff,(t)j )2)
Draw τ˜2,(t) ∼ IG(0.5J, 0.5||µ(t) −Xβ˜(t−1)||2)
Draw τ2,(t) ∼ IG(0.5J, 0.5||µdiff,(t) −Xβ(t−1)||2)
Draw β˜
(t) ∼N({τ˜−2,(t)XTX + D˜−2}−1τ˜−2,(t)XTµ(t), {τ˜−2,(t)XTX + D˜−2}−1)
Draw β(t) ∼N({τ−2,(t)XTX +D−2}−1τ−2,(t)XTµdiff,(t), {τ−2,(t)XTX +D−2}−1)
For candidate variables k = 1, ... K,
Draw wk ∼ Bern
(
1
1+BFk
)
, where BFk =
N(βk|0,0.12)
N(βk|0,1/γk)
Draw w˜k ∼ wk ∗ Bern
(
1
1+B˜Fk
)
, where B˜F k =
N(β˜k|0,0.12)
N(β˜k|0,1/γ˜k)
Update D˜ and D based on the new draws for w˜ and w.
Draw γ˜
2,(t)
k ∼ IG(2.5 + 0.5w˜(t)k , 2.5 ∗ 52 + 0.5w˜(t)k β˜2,(t)k )
Draw γ
2,(t)
k ∼ IG(2.5 + 0.5w(t)k , 2.5 ∗ 52 + 0.5w(t)k β2,(t)k )
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